NanoBarium

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameNanoBarium
Drug Alias NameN/A
ClassificationDiagnostic agent (In vivo)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGastrointestinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorwayUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSterling Winthrop Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsGastrointestinal Diseases

Other Information

ATC CodeN/A
Related LinksN/A